Page 1175 - Veterinary Immunology, 10th Edition
P. 1175

cells suggests that they originate from a clone of myeloid cells that
  VetBooks.ir  arose in a wolf or East Asian breed of dog about 10,000 years ago.




               Devil Facial Tumor Disease

               The large carnivorous marsupial, the Tasmanian devil (Sarcophilus

               harrissii), is on the brink of extinction as a result of devil facial
               tumor disease, a transmissible cancer. This disease first appeared in
               1996 and has spread across Tasmania. It has reduced some devil

               populations by as much as 90%. Tumor cells are transmitted when
               devils bite each other around the face, a common behavior. Animals
               die within 3 to 6 months of acquiring the cancer since they are
               unable to mount an immune response to the foreign cells. The
               tumor cells grow and form a large mass that is eventually lethal

               (Fig. 35.8). Almost very devil “infected” with these tumor cells dies
               of cancer. Although devils have a functioning immune system, their
               limited MHC diversity prevents them from recognizing the tumor

               cells as foreign. (The tumor cells originated from Schwann cells
               from a female devil in the early-1990s but are continuing to evolve.)
               A second, genetically distinct facial tumor lineage (DFT2) has also
               been recognized in devils. Facial tumor cells do not express surface
               MHC class I due to down-regulation of their β2-microglobulin and

               TAP genes. This downregulation is a result of epigenetic
               deacetylation of histones. Thus there is no histocompatibility barrier
               to tumor growth. Although devils have functioning NK cells these

               cannot kill the tumor cells for unknown reasons. MHC expression
               can be restored by exposing facial tumor cells to recombinant devil
               IFN-γ and subsequent activation of the MHC class II transactivator,
               a critical transcription factor. Blood mononuclear cells activated by
               mitogens in vitro can also kill devil tumor cells. Encouraging results

               have also been obtained by vaccinating animals with killed
               adjuvanted tumor cells. It also appears that resistance to this cancer
               is emerging in some wild populations.

















                                                        1175
   1170   1171   1172   1173   1174   1175   1176   1177   1178   1179   1180